Free tool
Stocks listed on NYSE
We cover 118 companies listed on NYSE. The median market value in the group is $10.34B. Across the group, the median move over the past trading day is +0.25%. 78% of the 116 with a 200-day average trade above it. Price change over the past year runs from −35.1% to +90.6% across the middle 80 percent of the group, with a median of +14.2%. Across the group, 4 companies currently carry a tier A volume signal.
Other lists in this group
Table
118 of 1,978 companies match these filters.Clear filters
| Ticker | Company | Market cap (USD) | Size | 1Y return |
|---|---|---|---|---|
| LLY | Eli Lilly and Company | $1.10T | Mega cap | +78.28% |
| JNJ | Johnson & Johnson | $658.24B | Mega cap | +56.92% |
| ABBV | AbbVie Inc. | $469.68B | Mega cap | +31.10% |
| MRK | Merck & Co., Inc. | $371.70B | Mega cap | +88.17% |
| NVS | Novartis AG | $300.35B | Mega cap | +31.84% |
| AZN | AstraZeneca PLC | $263.12B | Mega cap | +7.60% |
| TMO | Thermo Fisher Scientific Inc. | $232.26B | Mega cap | +28.46% |
| NVO | Novo Nordisk A/S | $215.18B | Mega cap | −10.46% |
| ABT | Abbott Laboratories | $202.28B | Mega cap | −10.54% |
| PFE | Pfizer Inc. | $159.42B | Large cap | +19.52% |
| DHR | Danaher Corporation | $151.82B | Large cap | +4.52% |
| BMY | Bristol-Myers Squibb Company | $138.74B | Large cap | +49.31% |
| SYK | Stryker Corporation | $126.81B | Large cap | −14.79% |
| MDT | Medtronic plc | $116.66B | Large cap | +1.33% |
| MCK | McKesson Corporation | $105.52B | Large cap | +33.71% |
| GSK | GSK plc | $104.29B | Large cap | +34.79% |
| HCA | HCA Healthcare, Inc. | $95.12B | Large cap | +6.96% |
| ELV | Elevance Health, Inc. | $86.50B | Large cap | +29.17% |
| CI | The Cigna Group | $73.81B | Large cap | −5.62% |
| BSX | Boston Scientific Corporation | $72.26B | Large cap | −52.56% |
| COR | Cencora, Inc. | $62.60B | Large cap | +14.44% |
| TAK | Takeda Pharmaceutical Company Limited | $58.60B | Large cap | +21.77% |
| CAH | Cardinal Health, Inc. | $55.33B | Large cap | +64.25% |
| EW | Edwards Lifesciences Corporation | $52.32B | Large cap | +12.38% |
| BDX | Becton, Dickinson and Company | $51.69B | Large cap | +26.17% |
| HUM | Humana Inc. | $46.42B | Large cap | +32.71% |
| HLN | Haleon plc | $44.77B | Large cap | +6.56% |
| TEVA | Teva Pharmaceutical Industries Limited | $44.40B | Large cap | +110.26% |
| A | Agilent Technologies, Inc. | $43.33B | Large cap | +30.69% |
| IQV | IQVIA Holdings Inc. | $42.70B | Large cap | +37.97% |
| WAT | Waters Corporation | $40.69B | Large cap | +38.63% |
| VEEV | Veeva Systems Inc. | $40.09B | Large cap | −13.47% |
| ALC | Alcon Inc. | $35.47B | Large cap | −8.71% |
| RMD | ResMed Inc. | $34.13B | Large cap | −16.58% |
| CNC | Centene Corporation | $32.11B | Large cap | +123.52% |
| ZTS | Zoetis Inc. | $31.94B | Large cap | −49.59% |
| MTD | Mettler-Toledo International Inc. | $28.10B | Large cap | +8.72% |
| LH | Labcorp Holdings Inc. | $27.39B | Large cap | +23.25% |
| DGX | Quest Diagnostics Incorporated | $26.99B | Large cap | +38.70% |
| PHG | Koninklijke Philips N.V. | $26.81B | Large cap | +3.60% |
| WST | West Pharmaceutical Services, Inc. | $24.52B | Large cap | +41.31% |
| STE | STERIS plc | $23.05B | Large cap | −4.35% |
| THC | Tenet Healthcare Corporation | $21.89B | Large cap | +54.57% |
| ZBH | Zimmer Biomet Holdings, Inc. | $19.12B | Large cap | −5.86% |
| SOLV | Solventum Corporation | $15.59B | Large cap | +25.92% |
| CRL | Charles River Laboratories International, Inc. | $14.21B | Large cap | +81.37% |
| RVTY | Revvity, Inc. | $13.93B | Large cap | +35.78% |
| BAX | Baxter International Inc. | $13.59B | Large cap | +7.91% |
| PEN | Penumbra, Inc. | $12.75B | Large cap | +22.79% |
| FMS | Fresenius Medical Care AG | $12.51B | Large cap | −3.29% |
| SNN | Smith & Nephew plc | $12.23B | Large cap | −19.49% |
| ELAN | Elanco Animal Health Incorporated | $12.20B | Large cap | +41.03% |
| EHC | Encompass Health Corporation | $11.85B | Large cap | −1.16% |
| DVA | DaVita Inc. | $11.41B | Large cap | +29.47% |
| GMED | Globus Medical, Inc. | $11.14B | Large cap | +35.16% |
| GKOS | Glaukos Corporation | $10.70B | Large cap | +98.13% |
| BIO | Bio-Rad Laboratories, Inc. | $10.45B | Large cap | +31.26% |
| MOH | Molina Healthcare, Inc. | $10.42B | Large cap | +13.96% |
| UHS | Universal Health Services, Inc. | $10.40B | Large cap | −4.14% |
| RDY | Dr. Reddy's Laboratories Limited | $10.28B | Large cap | −14.66% |
| BIO-B | Bio-Rad Laboratories, Inc. | $9.77B | Mid cap | +47.78% |
| AVTR | Avantor, Inc. | $9.75B | Mid cap | +9.16% |
| OSCR | Oscar Health, Inc. | $9.55B | Mid cap | +85.10% |
| QGEN | Qiagen N.V. | $9.01B | Mid cap | −10.74% |
| ATR | AptarGroup, Inc. | $8.57B | Mid cap | −2.35% |
| HIMS | Hims & Hers Health, Inc. | $7.41B | Mid cap | −26.15% |
| HNGE | Hinge Health, Inc. | $7.25B | Mid cap | +63.19% |
| CHE | Chemed Corporation | $7.11B | Mid cap | +19.61% |
| PACS | PACS Group, Inc. | $7.00B | Mid cap | +272.69% |
| BLCO | Bausch + Lomb Corporation | $6.16B | Mid cap | +18.72% |
| STVN | Stevanato Group S.p.A. | $6.08B | Mid cap | +3.23% |
| TFX | Teleflex Incorporated | $5.94B | Mid cap | +10.85% |
| HAE | Haemonetics Corporation | $4.93B | Mid cap | +96.13% |
| DOCS | Doximity, Inc. | $4.51B | Mid cap | −62.74% |
| CON | Concentra Group Holdings Parent, Inc. | $4.44B | Mid cap | +49.74% |
| NVST | Envista Holdings Corporation | $4.39B | Mid cap | +30.07% |
| ITGR | Integer Holdings Corporation | $4.25B | Mid cap | +15.26% |
| MANE | Veradermics, Incorporated | $4.11B | Mid cap | +171.13% |
| RCUS | Arcus Biosciences, Inc. | $4.02B | Mid cap | +211.03% |
| OGN | Organon & Co. | $3.61B | Mid cap | +52.78% |
| WRBY | Warby Parker Inc. | $3.24B | Mid cap | −0.61% |
| BKD | Brookdale Senior Living Inc. | $2.91B | Mid cap | +59.90% |
| BHC | Bausch Health Companies Inc. | $2.50B | Mid cap | −7.81% |
| NUVB | Nuvation Bio Inc. | $2.49B | Mid cap | +146.53% |
| PBH | Prestige Consumer Healthcare Inc. | $2.46B | Mid cap | −21.64% |
| BFLY | Butterfly Network, Inc. | $2.41B | Mid cap | +483.23% |
| GRDN | Guardian Pharmacy Services, Inc. | $2.36B | Mid cap | +42.20% |
| MD | Pediatrix Medical Group, Inc. | $2.19B | Mid cap | +58.21% |
| BHVN | Biohaven Ltd. | $2.17B | Mid cap | −3.75% |
| SEM | Select Medical Holdings Corp | $2.05B | Mid cap | +26.87% |
| PRGO | Perrigo Company plc | $2.01B | Mid cap | −36.97% |
| SNDA | Sonida Senior Living, Inc. | $1.97B | Small cap | +57.21% |
| INSP | Inspire Medical Systems, Inc. | $1.77B | Small cap | −34.28% |
| AGL | agilon health, inc. | $1.61B | Small cap | +178.58% |
| ARDT | Ardent Health, Inc. | $1.59B | Small cap | −10.95% |
| CNMD | CONMED Corporation | $1.53B | Small cap | −5.45% |
| ENOV | Enovis Corporation | $1.48B | Small cap | −17.46% |
| ANRO | Alto Neuroscience, Inc. | $1.42B | Small cap | +821.57% |
| AMN | AMN Healthcare Services, Inc. | $1.31B | Small cap | +63.90% |
| AORT | Artivion, Inc. | $1.29B | Small cap | −39.45% |
| AVNS | Avanos Medical Inc | $1.17B | Small cap | +115.43% |
| USPH | U.S. Physical Therapy, Inc. | $1.15B | Small cap | −7.75% |
| TDOC | Teladoc Health, Inc. | $1.12B | Small cap | −19.30% |
| PHR | Phreesia, Inc. | $711.64M | Small cap | −62.09% |
| GMRS | GMR Solutions Inc. | $686.08M | Small cap | −9.16% |
| CTEV | Claritev Corporation | $637.90M | Small cap | −47.44% |
| WEAV | Weave Communications, Inc. | $583.19M | Small cap | −4.33% |
| EVH | Evolent Health, Inc. | $552.86M | Small cap | −49.59% |
| DNA | Ginkgo Bioworks Holdings, Inc. | $507.75M | Small cap | −37.43% |
| EVMN | Evommune, Inc. | $500.47M | Small cap | −31.83% |
| AUNA | Auna SA | $391.02M | Small cap | −15.11% |
| EBS | Emergent BioSolutions Inc. | $289.18M | Small cap | −38.70% |
| AMWL | American Well Corporation | $199.17M | Small cap | +67.29% |
| OWLT | Owlet, Inc. | $151.95M | Small cap | −29.63% |
| ADCT | ADC Therapeutics SA | $132.77M | Small cap | −66.34% |
| ACH | Accendra Health, Inc. | $89.21M | Micro cap | −77.39% |
| ANVS | Annovis Bio, Inc. | $77.54M | Micro cap | −18.75% |
| CCM | Concord Medical Services Holdings Limited | $21.49M | Micro cap | −10.65% |
Covers ~22,000 companies across the US, Europe and Asia-Pacific (ex mainland China, Hong Kong and India), refreshed nightly. Every listed stock opens as a full analysis for $9.90.